---
title: "NeuroOne Medical Technologies Corporation (NMTC.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/NMTC.US.md"
symbol: "NMTC.US"
name: "NeuroOne Medical Technologies Corporation"
industry: "医疗器械"
---

# NeuroOne Medical Technologies Corporation (NMTC.US)

| Item | Detail |
|------|--------|
| Industry | 医疗器械 |
| Location | 美股市场 |
| Website | [nmtc1.com](https://nmtc1.com) |

## Company Profile

NeuroOne Medical Technologies Corporation 是一家医疗技术公司，提供在美国进行连续脑电图（cEEG）和立体电生理图（sEEG）记录的解决方案。该公司还为患有癫痫、三叉神经痛、帕金森病、肌张力障碍、原发性震颤以及因背部手术失败和其他与疼痛相关的神经系统疾病而导致的慢性疼痛的患者提供脊髓刺激、脑刺激、药物输送和消融解决方案。该公司总部位于明尼苏达州的伊登草原

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-27T04:30:18.000Z

**Overall: B (0.35)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 37 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 103.78% |  |
| Net Profit YoY | 5.00% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 5.45 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 34.89M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 11.72M |  |


**Multi Score**: B

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -146.27% | E |
| Profit Margin | -58.28% | E |
| Gross Margin | 6.16% | E |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 103.78% | A |
| Net Profit YoY | 5.00% | C |
| Total Assets YoY | 32.08% | A |
| Net Assets YoY | 118.10% | A |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -171.58% | D |
| OCF YoY | 103.78% | A |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.55 | A |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 25.36% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - NeuroOne Medical Technologies Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-146.27%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-58.28%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "6.16%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "103.78%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "5.00%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "32.08%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "118.10%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-171.58%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "103.78%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.55",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "25.36%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 启迪医疗 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 雅培 (US.ABT) | B | C | C | B | C | B |
| 04 | 直觉外科 (US.ISRG) | A | B | C | A | B | B |
| 05 | 史赛克 (US.SYK) | A | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -5.11 | 121/181 | - | - | - |
| PB | 5.45 | 96/181 | 26.24 | 6.36 | 4.94 |
| PS (TTM) | 2.98 | 71/181 | 6.39 | 5.28 | 3.76 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-18T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 1 | 50% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.69 |
| Highest Target | 3.00 |
| Lowest Target | 1.60 |

## References

- [Company Overview](https://longbridge.com/en/quote/NMTC.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/NMTC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/NMTC.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.